APA

Njiaju U. O., Tevaarwerk A. J., Kim K., Chang J. E., Hansen R. M., Champeny T. L., Traynor A. M., Meadows S., Van Ummersen L., Powers K. & Stewart J. A. (20130408). Capecitabine and oxaliplatin in combination as first- or second-line therapy for metastatic breast cancer: a Wisconsin Oncology Network trial. : Cancer chemotherapy and pharmacology.

Chicago

Njiaju U O, Tevaarwerk A J, Kim K, Chang J E, Hansen R M, Champeny T L, Traynor A M, Meadows S, Van Ummersen L, Powers K and Stewart J A. 20130408. Capecitabine and oxaliplatin in combination as first- or second-line therapy for metastatic breast cancer: a Wisconsin Oncology Network trial. : Cancer chemotherapy and pharmacology.

Harvard

Njiaju U. O., Tevaarwerk A. J., Kim K., Chang J. E., Hansen R. M., Champeny T. L., Traynor A. M., Meadows S., Van Ummersen L., Powers K. and Stewart J. A. (20130408). Capecitabine and oxaliplatin in combination as first- or second-line therapy for metastatic breast cancer: a Wisconsin Oncology Network trial. : Cancer chemotherapy and pharmacology.

MLA

Njiaju U O, Tevaarwerk A J, Kim K, Chang J E, Hansen R M, Champeny T L, Traynor A M, Meadows S, Van Ummersen L, Powers K and Stewart J A. Capecitabine and oxaliplatin in combination as first- or second-line therapy for metastatic breast cancer: a Wisconsin Oncology Network trial. : Cancer chemotherapy and pharmacology. 20130408.